Philippines will be the first country in Asia outside Japan to see the launch of a health supplement that includes LC-Plasma.
The product, called ULTABIO with IMMUSE® contains Lactococcus lactis strain plasma (LC-Plasma) postbiotic, the immune-system-related functional ingredient found in iMUSE/IMMUSE products.
Theoxis Health Ventures, Inc. (Theoxis), affiliated to Kirin Holdings, has launched the product. ULTABIO with IMMUSE® is a flagship product of Theoxis.
The product can easily be fit into one’s daily routine simply by ingesting 2 capsules per day with water. It can now be bought at selected health stores as well as online in the Philippines.
Kirin, previously a dominant player in the brewery segment only, has diversified in the 1980s into the pharmaceutical business, and is now giving strong focus on boosting its Health Sciences division. Under the Kirin Group Vision 2027, a long-term management plan launched in 2019, the Kirin Group aims to become a global leader in CSV, creating value across our world of Food & Beverages to Pharmaceuticals.
